Remdesivir-Induced Liver Injury in a Patient With Coronavirus Disease 2019 and History of Congestive Hepatopathy

Remdesivir is an antiviral agent used as supportive care in adults with SARS-COV2-induced pneumonia. We report a case of an 81-year-old patient who developed hepatocellular acute liver injury 48 hours after initiating remdesivir. During the investigation, other causes of hepatotoxicity were excluded...

Descripción completa

Detalles Bibliográficos
Autores principales: Dividis, Georgios P, Papadopoulos, Georgios E, Karageorgiou, Ioannis, Kotronis, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733800/
https://www.ncbi.nlm.nih.gov/pubmed/36514704
http://dx.doi.org/10.7759/cureus.32353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733800/
https://www.ncbi.nlm.nih.gov/pubmed/36514704
http://dx.doi.org/10.7759/cureus.32353

Ejemplares similares